Cochlear Limited (CHEOF) Comparison with companies in other sectors?

Cochlear Limited has a share price of 65.23M. You can analyze Cochlear Limited (CHEOF) competitors across different market sectors through stock heatmaps.

What are CHEOF's NET and operating margins?

Cochlear Limited (CHEOF) operating margin is around 0.22, and net profit margin is approximately 0.16 as of the latest reports.

In what way does CHEOF's earnings per share (EPS) trend reflect its financial momentum?

Cochlear Limited (CHEOF) EPS is 3.71 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Cochlear Limited is 55.99, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Cochlear Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Cochlear Limited like P/E which is 58.64, P/B which is 11.37, and PEG which is 20.43. Compare them with sector averages to evaluate if the stock is priced fairly.

Cochlear Limited

CHEOF•PNK

Healthcare

Medical - Devices

$207.71

$0.00(0.00%)

Fundamental Analysis of Cochlear Limited (CHEOF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$3.71

P/E Ratio

55.99

ROE

0.20%

Net Margin

0.16%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$13.55B

Shares OutstandingTotal number of shares issued

$65.23M

Book Value/ShareNet worth per share

$28.009

Revenue/ShareAnnual revenue per share

$34.25

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$3.71

Net MarginNet income as percentage of revenue

15.85%

Operating MarginOperating income as percentage of revenue

21.70%

ROEReturn on shareholders' equity

19.70%

ROAReturn on total assets

13.00%

ROCEReturn on capital employed

23.11%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$4.66

Cash/ShareCash and equivalents per share

$9.38

FCF YieldFree cash flow as percentage of market cap

1.48%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$4.25

Dividend YieldAnnual dividend as percentage of stock price

1.33%

Financial Ratios Analysis data is not available for CHEOFFinancial Ratios Analysis details for CHEOF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CHEOFSector Benchmarking details for CHEOF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Cochlear Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Cochlear Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Cochlear Limited's unique business strengths and challenges.

Key Financial Metrics for Cochlear Limited

For Cochlear Limited, essential financial indicators include EPS 3.71, PE 55.99, and ROE 0.20. These key ratios reveal insights into Cochlear Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Cochlear Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Cochlear Limited

Metrics like Net Margin 15.85% and ROA 13.00% shed light on how well Cochlear Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Cochlear Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Cochlear Limited

Using ratios such as P/B Ratio 11.37 and PEG Ratio 20.43, investors can assess whether Cochlear Limited is appropriately valued based on its financials and growth potential. These figures, combined with Cochlear Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Cochlear Limited

Financial health indicators, such as Debt/Equity Ratio 0.13 and Cash Flow $4.66, provide a snapshot of Cochlear Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Cochlear Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Cochlear Limited

Investing in Cochlear Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Cochlear Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;